HIMS Hims & Hers Health Inc
- Stocks
- Consumer Defensive
- NYSE: HIMS
Price (delayed)
$57.32
Market cap
$12.83B
P/E Ratio
77.46
Dividend/share
N/A
EPS
$0.74
Enterprise value
$12.62B
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual
Highlights
Hims & Hers Health's revenue has soared by 86% YoY and by 21% from the previous quarter
HIMS's gross profit has soared by 74% YoY and by 17% from the previous quarter
Hims & Hers Health's quick ratio has decreased by 47% YoY and by 15% QoQ
Hims & Hers Health's gross margin has decreased by 7% YoY and by 3.1% QoQ
Key stats
What are the main financial stats of HIMS
Market
Valuations
Earnings
Shares outstanding
223.83M
Market cap
$12.83B
Enterprise value
$12.62B
Price to earnings (P/E)
77.46
Price to book (P/B)
23.18
Price to sales (P/S)
7.13
EV/EBIT
105.33
EV/EBITDA
86.4
EV/Sales
7.07
Revenue
$1.78B
Gross profit
$1.37B
Operating income
$109.9M
Net income
$164.4M
EBIT
$119.8M
EBITDA
$146.04M
Free cash flow
$236.51M
Per share
Balance sheet
Liquidity
EPS
$0.74
EPS diluted
$0.68
Free cash flow per share
$1.07
Book value per share
$2.47
Revenue per share
$8.04
TBVPS
$3.29
Total assets
$891.71M
Total liabilities
$342.45M
Debt
$63.38M
Equity
$549.26M
Working capital
$166.6M
Debt to equity
0.12
Current ratio
1.59
Quick ratio
1.16
Net debt/EBITDA
-1.45
Margins
Efficiency
Dividend
EBITDA margin
8.2%
Gross margin
77%
Net margin
9.2%
Operating margin
6.2%
Return on assets
24.5%
Return on equity
36%
Return on invested capital
77.2%
Return on capital employed
19.6%
Return on sales
6.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HIMS stock price
How has the Hims & Hers Health stock price performed over time
Intraday
-1.21%
1 week
14.66%
1 month
33.46%
1 year
154.64%
YTD
137.06%
QTD
14.98%
Financial performance
How have Hims & Hers Health's revenue and profit performed over time
Revenue
$1.78B
Gross profit
$1.37B
Operating income
$109.9M
Net income
$164.4M
Gross margin
77%
Net margin
9.2%
Hims & Hers Health's revenue has soared by 86% YoY and by 21% from the previous quarter
The operating income has soared by 78% QoQ
HIMS's gross profit has soared by 74% YoY and by 17% from the previous quarter
The company's operating margin rose by 48% QoQ
Price vs fundamentals
How does HIMS's price correlate with its fundamentals
Growth
What is Hims & Hers Health's growth rate over time
Valuation
What is Hims & Hers Health stock price valuation
P/E
77.46
P/B
23.18
P/S
7.13
EV/EBIT
105.33
EV/EBITDA
86.4
EV/Sales
7.07
Hims & Hers Health's EPS has increased by 28% QoQ
The stock's P/E is 17% less than its last 4 quarters average of 93.3
The price to book (P/B) is 111% higher than the last 4 quarters average of 11.0
The equity has surged by 59% year-on-year and by 15% since the previous quarter
The P/S is 98% higher than the last 4 quarters average of 3.6 and 70% higher than the 5-year quarterly average of 4.2
Hims & Hers Health's revenue has soared by 86% YoY and by 21% from the previous quarter
Efficiency
How efficient is Hims & Hers Health business performance
The ROIC is up by 38% since the previous quarter
Hims & Hers Health's return on sales has increased by 37% QoQ
The ROE has grown by 16% from the previous quarter
The company's return on assets rose by 9% QoQ
Dividends
What is HIMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HIMS.
Financial health
How did Hims & Hers Health financials performed over time
Hims & Hers Health's total assets is 160% higher than its total liabilities
Hims & Hers Health's total assets has surged by 99% YoY and by 26% QoQ
The company's total liabilities rose by 48% QoQ
The debt is 88% less than the equity
The equity has surged by 59% year-on-year and by 15% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.